Presently, targeting several biomarkers have been identified to enhance the radiosensitivity of NPC such as Bcl-2, VEGF, EGFR and AMPK which were associated with cell apoptosis, angiogenesis, cell cycle and DNA repair. The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.